4SC-202 activates ASK1-dependent mitochondrial apoptosis pathway to inhibit hepatocellular carcinoma cells

Meili Fu1, Fuqiang Wan2, Zhengling Li3

  • 1Department of Infectious Disease, Linyi People's Hospital, Linyi 276000, China.

Insights

The novel HDAC inhibitor 4SC-202 effectively kills hepatocellular carcinoma (HCC) cells by activating the ASK1-dependent mitochondrial apoptosis pathway. This targeted approach shows promise for treating liver cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Hepatocellular carcinoma (HCC) remains a significant global health challenge.
  • Targeting specific molecular pathways offers a promising strategy for HCC treatment.
  • Histone deacetylase inhibitors (HDACi) are emerging as potential anti-cancer agents.

Purpose of the Study:

  • To investigate the anti-HCC activity of 4SC-202, a novel class I HDAC inhibitor.
  • To elucidate the signaling mechanisms underlying 4SC-202's effects on HCC cells.

Main Methods:

  • Treatment of HCC cell lines and primary HCC cells with 4SC-202.
  • Analysis of apoptosis markers, including mitochondrial permeability transition pore (mPTP) opening, cytochrome C release, and caspase activation.
  • Investigating the role of cyclophilin-D (Cyp-D) and apoptosis signal-regulating kinase 1 (ASK1) in 4SC-202-induced apoptosis.
  • Utilizing caspase inhibitors, mPTP blockers, and shRNA-mediated knockdown.

Main Results:

  • 4SC-202 demonstrated potent cytotoxic and proliferation-inhibitory effects on various HCC cells.
  • 4SC-202 activated the mitochondrial apoptosis pathway, evidenced by mPTP opening and caspase activation.
  • ASK1 activation, translocation to mitochondria, and complexation with Cyp-D were crucial for 4SC-202-induced apoptosis.
  • Inhibition of this pathway significantly attenuated 4SC-202's anti-cancer effects.

Conclusions:

  • 4SC-202 potently inhibits human HCC cells through the activation of the ASK1-dependent mitochondrial apoptosis pathway.
  • This study identifies 4SC-202 as a potential therapeutic agent for HCC.
  • The findings highlight the critical role of the ASK1-Cyp-D complex in mediating HDACi-induced apoptosis in HCC.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.3K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.2K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
16.8K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.2K
Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside...
14.5K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.9K